Skip to content
OpenCapital
Get started

USCB Financial Holdings, Inc. USCB Trial Loan Modifications

Other financials

Income statement

See full
Revenue$26.2M+14.7%
Net income$9.4M+22.1%
EPS (diluted)$0.51+34.2%

Balance sheet

See full
Cash & equivalents$79.0M-19.4%
Total debt$4.8M-38.3%
Total equity$223.2M-0.8%
Total assets$2.8B+6.3%

Cash flow

See full
Operating cash flow$15.3M+4.4%
CapEx$320.0K+596%
Free cash flow$15.0M+2.6%

Valuation

See full
Market cap$363.27M+13.5%
Enterprise value$289.06M+25.8%
P/E13.1×+1.5×
P/S3.9×+0.2×

Profitability

See full
Net margin29.7%-1.8pp
FCF margin55.3%—

Returns & leverage

See full
Return on equity12.4%-0.8pp
Debt / equity0×0.0×

Where this comes from

Reported directly by USCB Financial Holdings, Inc. in its filing.

Tagged under the XBRL concept us-gaap:FinancingReceivableModificationsRecordedInvestment.

The official record: USCB Financial Holdings, Inc.’s 10-Q, filed May 8, 2026, on SEC EDGAR. View the filing →

Ask your AI about USCB Financial Holdings, Inc.'s trial loan modifications.

Connect your AI assistant and see it in context, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is USCB Financial Holdings, Inc.'s trial loan modifications?
USCB Financial Holdings, Inc. (USCB) reported trial loan modifications of $418K in Q1 2026.
How has USCB Financial Holdings, Inc.'s trial loan modifications changed year-over-year?
USCB Financial Holdings, Inc.'s trial loan modifications decreased by 10.7% year-over-year, from $468K to $418K.
What is the long-term trend for USCB Financial Holdings, Inc.'s trial loan modifications?
Over 2 years (2023 to 2025), USCB Financial Holdings, Inc.'s trial loan modifications has grown at a 22.1% compound annual growth rate (CAGR), from $650K to $969K.